Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here it is
I'm not understanding your ire. First you complain that they don't tell us enough, then complain when they tell us more than they have to. What about the word "aggregate" don't you understand? They said aggregate to DPS, so it is pre-split. I actually thought it was stated a bit deceptively for another reason. Though their words were very clear, people not astute to the DPS arrangement may have been led to believe this was the amount to PTSC. But you are here, you KNOW about the DPS arrangement if you've been paying attention. And I suspect PTSC has the expectation that investors are paying attention. Again, they didn't have to tell us about revenues for 1 June through 3 Oct, as those dates reside outside the FY reported. I don't mean to poke you with a pointy stick, but aren't you at least a little gratified that they chose to include this bit of info in advance? Now if they'd get the PR machine working. After all, the numbers are really good. I'm afraid we might have to wait till later in the month when that analyst report comes out, and hope they run with that. THAT, IMO, is the next big event that could propell the PPS. IF that report comes out and there's no associated PR, then you well see me expressing my ire! And not just here - I'll be calling Mr. Pohl! SGE
Share
New Message
Please login to post a reply